Related Experiment Video

Updated: Jul 23, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.9K

Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma

Qian Wang1, Chunwei Xu2,3,4, Wenxian Wang3

  • 1Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.

Thoracic Cancer
|July 17, 2023
PubMed

Insights

Malignant pleural mesothelioma (MPM) is a growing cancer requiring early detection. A new consensus standardizes MPM diagnosis and treatment for better patient outcomes.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Pulmonology

Background:

  • Malignant pleural mesothelioma (MPM) incidence is rising globally.
  • MPM presents insidiously, often diagnosed at late stages, necessitating early screening.
  • Current treatments include surgery, chemotherapy, radiotherapy, immunotherapy, and electric field therapy.

Purpose of the Study:

  • To establish a national consensus on the clinical diagnosis and treatment of MPM in China.
  • To standardize MPM management based on evidence and expert opinion.
  • To guide early screening and treatment for high-risk populations.

Main Methods:

  • Development of a consensus by the Mesothelioma Group of the Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee).
  • Review of existing clinical research evidence.
  • Incorporation of national expert opinions.

Main Results:

  • A comprehensive consensus document covering epidemiology, diagnosis, treatment, and follow-up of MPM.
  • Recommendations for promoting standardized and homogenized MPM care.
  • Emphasis on early detection and tailored treatment strategies.

Conclusions:

  • The developed consensus provides a framework for consistent MPM diagnosis and treatment in China.
  • Standardization of care is expected to improve patient outcomes and survival rates.
  • The consensus addresses the critical need for improved management of this challenging malignancy.
Keywords:
diagnosismalignant pleural mesotheliomaprognosistreatment

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.9K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.2K

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
246
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
218
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K